Literature DB >> 17184514

Mechanisms of sympathetic activation in heart failure.

A M D Watson1, S G Hood, C N May.   

Abstract

1. Heart Failure (HF) is a serious, debilitating condition with poor survival rates and an increasing level of prevalence. A characteristic of HF is a compensatory neurohumoral activation that increases with the severity of the condition. 2. The increase in sympathetic activity may be beneficial initially, providing inotropic support to the heart and peripheral vasoconstriction, but in the longer term it promotes disease progression and worsens prognosis. This is particularly true for the increase in cardiac sympathetic nerve activity, as shown by the strong inverse correlation between cardiac noradrenaline spillover and prognosis and by the beneficial effect of beta-adrenoceptor antagonists. 3. Possible causes for the raised level of sympathetic activity in HF include altered neural reflexes, such as those from baroreceptors and chemoreceptors, raised levels of hormones, such as angiotensin II, acting on circumventricular organs, and changes in central mechanisms that may amplify the responses to these inputs. 4. The control of sympathetic activity to different organs is regionally heterogeneous, as demonstrated by a lack of concordance in burst patterns, different responses to reflexes, opposite responses of cardiac and renal sympathetic nerves to central angiotensin and organ-specific increases in sympathetic activity in HF. These observations indicate that, in HF, it is essential to study the factors causing sympathetic activation in individual outflows, in particular those that powerfully, and perhaps preferentially, increase cardiac sympathetic nerve activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184514     DOI: 10.1111/j.1440-1681.2006.04523.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  27 in total

1.  Intrathecal injection of TRPV1 shRNA leads to increases in blood pressure in rats.

Authors:  S-Q Yu; D H Wang
Journal:  Acta Physiol (Oxf)       Date:  2011-04-22       Impact factor: 6.311

Review 2.  Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review.

Authors:  Wolfram Doehner; Stephan von Haehling; Stefan D Anker; Mitja Lainscak
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  The relationship of stress and blood pressure effectors.

Authors:  C Ayada; Ü Toru; Y Korkut
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

Review 4.  The effects of heart rate control in chronic heart failure with reduced ejection fraction.

Authors:  Dario Grande; Massimo Iacoviello; Nadia Aspromonte
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 5.  The sympathetic nervous system and heart failure.

Authors:  David Y Zhang; Allen S Anderson
Journal:  Cardiol Clin       Date:  2014-02       Impact factor: 2.213

Review 6.  Angiotensin II, sympathetic nerve activity and chronic heart failure.

Authors:  Yutang Wang; Sai-Wang Seto; Jonathan Golledge
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

7.  Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts.

Authors:  Christoph Rischpler; Kenji Fukushima; Takuro Isoda; Mehrbod S Javadi; Robert F Dannals; Roselle Abraham; Richard Wahl; Frank M Bengel; Takahiro Higuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-29       Impact factor: 9.236

8.  Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats.

Authors:  Flávia Regina Carreño; Lisa L Ji; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-17       Impact factor: 3.619

9.  Symbolic analysis detects alterations of cardiac autonomic modulation in congestive heart failure rats.

Authors:  Eleonora Tobaldini; Alberto Porta; Shun-Guang Wei; Zhi-Hua Zhang; Joseph Francis; Karina Rabello Casali; Robert M Weiss; Robert B Felder; Nicola Montano
Journal:  Auton Neurosci       Date:  2009-04-28       Impact factor: 3.145

Review 10.  Device therapy to modulate the autonomic nervous system to treat heart failure.

Authors:  John C Lopshire; Douglas P Zipes
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.